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The shedding and liberation of the 17 kDa inflammatory
cytokine TNFα requires for this cytokine to be first
cleaved from its 24 kDa pro-form expressed in cell mem-
branes at the scissile Ala76-Val77 bond. This process is
presumed to rely largely on the action of metallopro-
teinase sheddases, foremost the TNFα-cleaving enzyme
(TACE or ADAM17) (Black et al., 1997). However, native
TACE contains an inhibitory cysteine switch, removal of
which seems a prerequisite for enzyme activity (Clarke
et al., 1998). We were puzzled, therefore, by the fact that
an acute release of soluble TNFα from the myocardium
begins immediately (0 – 30 min) upon post-ischemic
reperfusion of the heart (Kupatt et al., 1999; Massoudy
et al., 2000). Pertinently, this is a situation characterized
by oxidative stress (Raschke et al., 1993), and recent ev-
idence suggests that oxidation of the crucial cysteine lo-
cated at position 184 may acutely generate sheddase ac-
tivity without a preceeding enzymatic removal of the
entire switch (Gilles et al., 2001; Zhang et al., 2001). How-
ever, there is uncertainty concerning oxidative activation
of TACE in situ and which cells express TACE in the my-
ocardium, i.e., presumably serve as source for the liber-
ated TNFα. Another confusing issue is that a number of
other metalloproteinases, including MMPs-1, -7, -9 and -
17 and ADAM10, have been reported to cleave pro-
TNFα, and these proteases also are characterized by the
presence of an inhibitory cysteine switch (Haro et al.,
2000; English et al., 2000; Lunn et al., 1997).
Candidate cells capable of acutely liberating TNFα
(within minutes) via the action of TACE or related metallo-
proteinases under the inflammatory and oxidative condi-
tions of post-ischemic reperfusion include coronary en-
dothelial cells, resident mast cells (Frangogiannis et al.,
1998) and peripheral blood leukocytes (PBL), the latter
becoming adherent and emigrating into the heart tissue
in large numbers immediately upon reperfusion (Raschke
et al., 1993; Zahler et al., 1999). Typification of suitable
cells and elucidation of the mechanisms underlying acti-
vation of the sheddase(s) are confounded by the fact that
pure cell cultures such as human umbilical vein endothe-
lial cells (HUVEC) and HMC-1, a human mast cell-derived
tumor cell line (Butterfield et al., 1988) that expresses
TACE at the cell surface (Becker et al., 2002), do not gen-
erally express substantial amounts of pro-TNFα under
non-inflammatory conditions. Indeed, initial hopes of be-
ing able to measure the release of TNFα into the medium
(ELISA assay) or the shedding of TNFα from the cell
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Tumor necrosis factor- (TNF) is presumably shed
from cell membranes by TNF-cleaving enzyme
(TACE). The peptides SPLAQAVRSSSR and Dabcyl-
LAQAVRSSSR-Edans, each encompassing the cleav-
age sequence of pro-TNF recognized by TACE, were
applied to intact umbilical vein endothelium (HUVEC),
peripheral blood leukocytes (PBL) and the mast cell
line HMC-1, which express TACE, to homogenates of
rat heart tissue and to membrane and cytoplasmic
extracts of PBL. Formation of SPLAQA (specific
cleavage) was determined by HPLC, while cleavage
(specific plus non-specific) of Dabcyl-TNF-Edans
was followed over time by measuring fluorescence.
Participation of TACE was assessed from inhibition
due to the drug TAPI-2. Incubation with recombinant
human TACE gave specific cleavage, fully inhibitable
by TAPI-2 (IC50<0.1 µM). HUVEC rapidly degraded
TNF-peptide, but in a non-specific manner (no
SPLAQA detectable) and 50 µM TAPI-2 was without
effect. Fluorescence was evoked when Dabcyl-
LAQAVRSSSR-Edans was incubated with HMC-1 or
PBL and also with cytoplasmic and membrane frac-
tions of lysed PBL, but in no case was there signifi-
cant inhibition by TAPI-2. However, marginal (10%) in-
hibition of fluorescence by 50 µM TAPI-2 was
observed with homogenized heart tissue. This con-
tained TACE, about 75% of which was without the in-
hibitory cysteine switch (Western blot). In conclusion,
simple peptide analogs of pro-TNF cannot be em-
ployed as substrates for measuring membrane TACE
activity, largely due to extensive non-specific prote-
olytic cleavage by whole cells and cell extracts.
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Prolonged inflammatory prestimulation of the cells to
induce TNFα was no option, because we needed to
mimic the actute oxidative stress imposed on cells in
myocardial tissue during early reperfusion. Frequently,
ersatz markers of shedding of TNFα are determined, for
instance shedding of TNFα-receptors or of L-selectin
(Zhang et al., 2001), but their kinetics of cleavage by
TACE could be different from those of TNFα. Alterna-
tively, employing peptide substrates with sequences
identical to the scissile region of pro-TNFα in the ab-
sence and presence of known inhibitors of TACE (such
as TAPI-2) to probe the activity of endogenous TACE
could provide a possible solution (Black et al., 1997;
Zhang et al., 2001). However, extension of this technique
to whole cells and tissue homogenates has not been re-
ported. 
We first verified that the small peptide Ac-SPLAQA*
VRSSSR-NH2 and the cryptic fluorescent probe Dabcyl-
LAQA*VRSSSR-Edans, each encompassing the scissile
amino acid sequence of pro-TNFα, are proteolytically de-
graded by recombinant human TACE. Both substrates
suffered the expected rapid cleavage when incubated
with ‘Cat-Dis’ rhTACE (approx. 1 µM). In the latter case,
this is illustrated by increase of fluorescence (Figure 1). In
the case of Ac-SPLAQAVRSSSR-NH2 cleavage was spe-
cific, disappearance of the test peptide leading strictly to
a 1:1 formation of Ac-SPLAQA (data not shown). TAPI-2
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Fig. 1 Inhibition of Human Recombinant TACE by TAPI.
Human recombinant TACE (Cat-Dis domains, from Arg 215 to
Asn 671; 1 µg/ml) was incubated at room temperature in 50 mM
Tris (pH 7.4) with 10 µM Dabcyl-TNFα-Edans (Dabcyl-Leu-Ala-
Gln-Ala-Val-Ser-Ser-Ser-Arg-Edans; Bachem, Heidelberg, Ger-
many) in the absence or presence of 4 µM TAPI-2 [N-(R)-(2-(hy-
droxyaminocarbonyl)methyl)-4-methylpentanoyl-L-t-butyl-Gly-
L-alanine-2-aminoethylamide, Immunex, Seattle, USA and Pep-
tides International, Louisville, USA]. The plot shows one of
4 similar experiments. RFU = relative fluorescence units.
Fig. 2 Flow Cytometric Demonstration of TACE on HUVEC.
Shown is a representative experiment of three cultures. HUVEC were brought into suspension with citrate buffer and fixed with 1%
formaldehyde diluted in PBS (10 min, room temperature). After washing with Tyrode’s buffer, pH 7.4, and 3 rinsings with PBS, the cells
were covered with 0.2% BSA in PBS for 10 min and labeled with primary antibody against human TACE (1 µg/ml huTACE-M222 from
Immunex, in blocking buffer, 45 min, room temperature) and secondary antibody carrying phycoerythrin (lower panel). Control with sec-
ondary antibody alone (anti-mouse IgG, 30 min incubation at room temperature, 3 washings in PBS, resuspension in Tyrode´s buffer) is
shown in the upper panel.
membrane directly (flow cytometry) were not realized
(Becker et al., 2002). 
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inhibited cleavage of the substrates by rhTACE, giving
about 50% inhibition at 0.01 µM and and 95 – 100% at
concentrations >1 µM. The total inhibition of Dabcyl-
TNFα-Edans cleavage caused by 4 µM TAPI-2 is exempli-
fied in Figure 1.
Before commencing experiments with HUVEC and
heart tissue, it was necessary to demonstrate the expres-
sion of TACE. Staining of non-permeabilized HUVEC with
antibody against human TACE and subsequent analysis
by flow cytometry revealed the presence of immunoreac-
tive TACE on these cells (Figure 2). The intensity of ex-
pression was clearly non-homogeneous, some cells be-
ing without, and others with, high levels of TACE. Western
blots of extracts of homogenized rat heart tissue using an
antibody directed against the C-terminal (intracellular)
end of the TACE molecule demonstrated two bands: the
fainter one at a molecular mass of about 100 kDa, the far
stronger band at approx. 80 kDa (Figure 3, top). These
molecular masses correspond roughly to those expected
of the rat pro-enzyme with the cysteine switch attached
and the furin-processed enzyme, respectively (Milla et al.,
1999; Doedens and Black 2000; Swiss-Prot: www.ex-
pasy.ch/sprot/). Obviously, it is impossible to state from
which cells or cell compartments this TACE is derived.
The ratio of the two bands did not differ between hearts
subjected to a protocol of ischemia and reperfusion and
controls (Figure 3, bottom). These particular results are
intriguing, since they do not support any extensive prote-
olytic activation of TACE in reperfused myocardial tissue,
or even the need for any such conversion. However, facile
cleavage of substrate peptides should be expected, both
with HUVEC and homogenates.
Incubation of test peptides with whole cells (HUVEC,
HMC-1, PBL) or heart tissue homogenates did not yield
the same results as with rhTACE. Table 1 lists the extent
of degradation of Ac-SPLAQAVRSSSR-NH2 co-incubat-
ed for 1 or 24 h with confluent HUVEC at 37°C in PBS.
While no peptide remained intact for detection by HPLC
after 24 h of contact with HUVEC, about 45 – 55% of the
peptide was still detectable after 1 h, also irrespective of
oxidative (with H2O2 and HOCl) or inflammatory pre-stim-
ulation of the endothelial cells (see Table 1). This came as
a surprise, because TACE is reportedly activated by H2O2
(Zhang et al., 2001). Moreover, TNFα shedding in the
heart can be induced by intracoronary infusion of either
HOCl or H2O2 (Gilles et al., 2001). As an additional dis-
crepancy, TAPI-2 did not attenuate degradation, even at
50 µM. Importantly, under no condition was it possible to
find the specific cleavage product Ac-SPLAQA (Table 1).
This did not seem to be due to selective cellular uptake,
because Ac-SPLAQA co-incubated with HUVEC over 1 h
remained at a constant level in the supernatant (result not
shown). Uptake of TNFα-peptide into HUVEC cannot be
excluded. Most likely, however, non-specific cleavage by
other membrane proteases and peptidases may account
for its disappearance. Preliminary experiments indicate
that full inhibition of degradation can be achieved in the
presence of protease inhibitor cocktail plus ortho-
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Fig. 3 Determination by Western Blotting of TACE in Ho-
mogenates of Isolated Perfused Rat Hearts.
Top panel: representative Western blot. Two bands were detect-
ed by TACE antibody/chemiluminescence. The upper (approx.
100 kDa) band presumably represents the unprocessed precur-
sor (pro-TACE), while the lower (approx. 80 kDa) band corre-
sponds to mature TACE (lacking the prodomain). Total protein
loaded amounted to 50 µg (lanes 1 and 4), 33 µg (lanes 2 and 5)
and 25 µg (lanes 3 and 6). Bottom panel: ratio of unprocessed to
mature TACE in control hearts and hearts subjected to 15 min
global ischemia (37°C) and 120 min of reperfusion. There was no
significant difference between the two conditions (mean values
± SD, n = 4, p = 0.1 by t-test). Heart tissue was homogenized in
50 mM Tris-HCl, 1 mM DTT, 100 µM phenanthroline, 0.2% Non-
idet P-40, pH 7.4, mixed with Complete® protease inhibitor
cocktail (Roche Diagnostics, Mannheim, Germany). The sam-
ples were boiled for 7 min with 1/4 volume of 4× loading buffer
(250 mM Tris-HCl, pH 6.8; 8% SDS; 40% glycerol; 0.02% bro-
mophenol blue; 400 mM mercaptoethanol), and loaded on a
10% SDS polyacrylamide gel. After blotting onto a nitrocellulose
membrane with transfer buffer (39 mM glycine; 48 mM Tris base;
0.037% SDS; 10% methanol), proteins were blocked for 2 h
(blocking buffer 50 mM Tris base, pH 7.5; 10% horse serum; 3%
BSA; 200 mM NaCl; 0.05% Tween 20). Primary (rabbit anti-
TACE/ADAM17 polyclonal; Chemicon; 1:1000) and secondary
antibody were diluted in blocking buffer.
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Table 1 Incubation of the TNFα Test Peptide Ac-SPLAQAVRSSR-NH2 with HUVEC.
Incubation condition Amount of test + TAPI-2 Formation of
peptide remaining (% of initial) Ac-SPLAQA
(% of initial)
1 h 59±6.5 58±1 Not detectable
1 h + H2O2 (1 mM) 54±11 66±12 n.d.
1 h + HOCl (10 µM) 54±11 59±2 n.d.
1 h + IFNγ 46±9 _ n.d.
1 h + TNFα 51±8 _ n.d.
1 h + LPS 45±6 _ n.d.
1 h + PMA 52±9 _ n.d.
24 h 0 0 n.d.
24 h + H2O2 0 0 n.d.
24 h + HOCl 0 0 n.d.
TNFα test peptide (2 – 20 µM) was incubated with HUVEC (confluent, first passage) at 37°C in the
absence and presence of the TACE inhibitor TAPI-2 (50 µM), added before test peptide (mean val-
ues ± SD, n = 3 – 6, n.d. = not detectable). Interferon-γ (IFNγ, 250 ng/ml), TNFα (2.5 ng/ml) or
lipopolysaccharide (LPS, 100 ng/ml) were added to the cultures 24 h before peptide, HOCl (10 µM)
and phorbolmyristate (PMA, 10 µM) 10 min, and H2O2 (1 mM) 30 min prior to the test peptide. The
supernatant was acidified with 0.4 M HClO4, centrifuged and analyzed by HPLC simultaneously for
the 12-amino acid peptide substrate and the 6-amino acid fragment Ac-SPLAQA, one of the 2
TACE-specific cleavage products. The conditions used were: C18-Aqua® column (Phenomenex, As-
chaffenburg, Germany), isocratic elution with 32% HClO4 (pH 2) in methanol (41%) and water (27%),
peak detection at 200 nm (L-7400 detector, Hitachi-Merck, Darmstadt, Germany). Peak identifica-
tion and calibrations were performed with substrate degraded by recombinant human TACE and
with standard peptides (Biosource, Nivelles, Belgium). Retention times at a flow rate of 1 ml/min
were 10.1 min for Ac-SPLAQAVRSSSR-NH2 and 15.9 min for Ac-SPLAQA.
Fig. 4 Peptide Cleavage Assay with Whole Cells.
(A) HMC-1 cells (106/ml) incubated in Tyrode´s buffer at 37°C with 10 µM Dabcyl-TNFα-Edans in the absence or presence of TAPI-2.
(B) PBL (106/ml) in 250 mM Tris with 10 µM Dabcyl-TNFα-Edans. HOCl (10 µM) was added 10 min prior to peptide substrate. In each case,
the Figure depicts one of 3 similar experiments. Development of fluorescence was monitored over a total period of 45 min (HMC-1) or
300 min (PBL) using a microplate reader (SPECTRAFluor plus, TECAN, Salzburg, Austria) with excitation at 355 nm and emission at
495 nm. RFU = relative fluorescence units. The buffy coat obtained by centrifugation of fresh, citrated venous blood at 190 g for 15 min
was mixed with 6% HES solution. The suspension was then centrifuged at 50 g for 10 min, the supernatant transferred to a fresh tube
and centrifuged again at 380 g for 10 min. The pellet was resuspended in 5 ml of calcium-free PBS and carefully layered over 5 ml per-
coll (Pharmacia, diluted to a final density of 1.077 g/ml). After centrifugation for 25 min at 380 g, the interphase (PBL) was collected,
washed with, and resuspended in, calcium-free phosphate buffered saline (pH 7.4).
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phenanthroline, a universal inhibitor of metal-containing
proteases (data not shown).
Fluorogenic Dabcyl-TNFα-Edans peptide was cleaved
by HMC-1 cells. However, the time-dependent increase
in fluorescence was not influenced by TAPI-2, even when
applied at the high concentration of 10 µM (Figure 4A).
Similarly, freshly isolated peripheral blood leukocytes
(PBL) caused fluorescence when brought into contact
with Dabcyl-TNFα-Edans, but neither prestimulation of
the PBL with oxidant (HOCl) nor the presence of TAPI-2
(10 µM) had any noticeable effect on the rate or extent of
peptide cleavage (Figure 4B). No increase in fluores-
cence was observed when the reagent was kept in buffer
without cells or when PBL were incubated alone. Previ-
ous studies with oxidants and HMC-1 cells had also
failed to uncover TACE activation (Becker et al., 2002). It
should be kept in mind that fluorescence of Dabcyl-
TNFα-Edans is elicited by peptide cleavage at any site of
the molecule. The reaction could, thus, very well be due
to any number of peptidases or proteases expressed on
the surface of HMC-1 cells and PBL.
Since TACE should be present in the membrane of
PBL, cells were lysed and various fractions prepared: cy-
toplasmic, soluble membrane and insoluble membrane.
As demonstrated in Figure 5, fluorogenic substrate was
cleaved by all 3 preparations at approx. equal rates.
Again, TAPI-2 was without any significant influence. Fi-
nally, tissue homogenates were prepared from isolated
perfused rat hearts that had been subjected to transient
global ischemia (15 min) and then reperfused for 65 min,
or that had been perfused without intermission (controls).
As illustrated in Figure 6, fluorescence was emitted from
Dabcyl-TNFα-Edans in both types of homogenate, but
there was no significant difference in the rate of substrate
turnover. TAPI-2 (50 µM) did cause a slight (approx. 10%)
reduction in fluorescence in each case (Figure 6), howev-
er, the effect was not statistically significant.
In conclusion, Cat-Dis TACE without the cysteine
switch can readily cleave TNFα test peptides in vitro. Also
whole cells can cleave the substrate peptides, but the
contribution made by TACE seems marginal (non-specif-
ic cleavage, lack of inhibition by TAPI, avid cleavage by
both membrane and non-membrane fractions of lysed
PBL). Alternative processes, such as degradation by oth-
er metalloproteinases or peptidases, and perhaps uptake
into cells, dominate substrate turnover. Activation of pro-
TACE is presumed to require removal of the cysteine
switch by a furin-type enzyme (Black et al., 1997; Doe-
dens and Black 2000; Milla et al., 1999; Skovronsky et al.,
2001). Which form of TACE is present at cell membranes
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Fig. 5 TACE Activity in Cell Fractions of Lysed PBL.
Aliquots (15 µl) of cytoplasmic, soluble or insoluble membrane
fractions (suspension) were incubated with 10 µM Dabcyl-TNFα-
Edans at 37°C in 200 µl of 50 mM Tris (pH 7.4) in the absence or
presence of 50 µM TAPI-2. Fluorescence was measured after
60 min (mean values ± SEM, RFU = relative fluorescence units).
There were no significant effects of TAPI in any fraction (paired t-
test). For lysis, 107 PMN in 50 µl of PBS were alternatingly frozen
(5 min, – 20°C) and thawed (5 min, 37°C) 5 times. Lysed cells
were then centrifuged (20 000 g, 15 min, 4°C). The supernatant
corresponded to the cytoplasmic fraction, the pellet to mem-
brane fractions. Pellets were resuspended in 30 µl of solubiliza-
tion buffer (10 µg/ml leupeptin; 400 µM benzamidine; 5 µM pep-
statin A; 2 µg/ml aprotinin; 1% Triton X-100 in PBS) and stirred
lightly for 2 hours at 4°C. Finally, these samples were cen-
trifuged (20 000 g, 4°C, 30 min), solubilized membrane proteins
being found in the supernatant, insoluble membrane compo-
nents in the pellet.
Fig. 6 TACE Activity in Rat Heart Homogenates.
Dabcyl-TNFα-Edans (10 µM) was incubated with rat heart ho-
mogenates in assay buffer for 45 min in the absence and pres-
ence of 50 µM TAPI-2 and fluorescence was measured every
5 min. Average rate of increase in fluorescence, normalized to
amount of protein in the assay, is plotted on the ordinate (mean
values ± SD, n.s. = not significant). Ischemia/reperfusion (15 and
65 min, respectively) did not significantly increase substrate
turnover vs. homogenates from control hearts (80 min perfusion
without ischemia). TAPI-2 treatment had only a slight inhibitory
effect in both groups (p = 0.1 for controls, p = 0.06 for is-
chemia/reperfusion by paired t-test). Homogenates were pre-
pared in buffer containing 50 mM Tris-HCl, 320 mM sucrose,
1 mM DTT, 10 µg/ml leupeptin, 2 µg/ml aprotinine, 10 mM
NaMoO4, 5 mM NaF and 0.2% Nonidet P-40 (pH 7.4). Super-
natants obtained by centrifugation (20 min, 3900 g, 4°C) were di-
luted 1:10 in assay buffer (50 mM Tris-HCl; 1 mM DTT; 10 mM
NaMoO4; 5 mM NaF; 100 µM ZnCl2; pH 7.4); for details of heart
perfusion, see Kupatt et al., 1999.
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is not quite certain (Schlöndorff et al., 2000). The failure to
uncover TACE activity by imposing oxidative stress on
the perfused heart prior to homogenization, or on cells in
culture, may relate to the fact that TACE is already pres-
ent largely in the pre-cleaved, mature form (Western blot
data) or that alternative, redox-insensitive peptidases
predominate. Thus, liberation of 17 kDa TNFα from the
post-ischemic heart may be more a question of acutely
enhanced access of pro-TNFα to mature TACE. Certain-
ly again open to question is whether TACE is really the
sheddase primarily responsible for acute release of TNFα
from the myocardium.
Acknowledgements
This work was supported by SFB469 of the German Research
Council (DFG). We are indebted to Dr. Roy Black of Immunex
Corporation, Seattle, WA, USA, for generously supplying TAPI-2,
TNFα-test peptide, active rhTACE and antibody against human
TACE, and to Dr. Ulf Neumann, Novartis Pharma, Bern, Switzer-
land, for also providing rhTACE. Contacts to the above scientists
were initiated by Dr. Marianne Jochum, Dept. of Clinical Chem-
istry and Clinical Biochemistry of the University of Munich, and
we acknowledge this help.
References
Becker, B.F., Gilles, S., Gonscherowski, V., Gabrijelcic-Geiger,
D., Sommerhoff, C., Welsch, U., and Zahler, S. (2002). As-
sessing experimental models in myocardial injury: lack of
activation of the proteases TACE and calpain in brief is-
chaemia and reperfusion. Heart, Lung Circ., in press.
Black, R.A., Rauch, C.T., Kozlosky, C.J., Peschon, J.J., Slack,
J.L., Wolfson, M.F., Castner, B.J., Stocking, K.L., Reddy, P.,
Srinivasan, S., Nelson, N. et al. (1997). A metalloproteinase
disintegrin that releases tumor-necrosis factor-α from cells.
Nature 385, 729 – 733.
Butterfield, J.H., Weiler, D., Dewald, G., and Gleich, G.J. (1988).
Establishment of an immature mast cell line from a patient
with mast cell leukemia. Leukemia Res. 12, 345 – 355.
Clarke, H.R., Wolfson, M.F., Rauch, C.T., Castner, B.J., Huang,
C.P., Gerhart, M.J., Johnson, R.S., Cerretti, D.P., Paxton, R.J.,
Price, V.L., and Black, R.A. (1998). Expression and purification
of correctly processed, active human TACE catalytic domain
in Saccharomyces cervisiae. Protein Expr. Purif. 13, 104 – 110.
Doedens, J.R., and Black, R.A. (2000). Stimulation-induced
down-regulation of tumor necrosis factor-α converting en-
zyme. J. Biol. Chem. 275, 14598 – 14607.
English, W.R., Puente, X.S., Freije, J.M.P., Knäuper, V., Amour, A.,
Merryweather, A., López-Otín, C., and Murphy, G. (2000).
Membrane type 4 matrix metalloproteinase (MMP-17) has tu-
mour necrosis factor-α convertase activity but does not acti-
vate pro-MMP-2. J. Biol. Chem. 275, 14046 – 14055.
Frangogiannis, N.G., Lindsey, M.L., Michael, L.H., Youker, K.A.,
Bressler, R.B., Mendoza, L.H., Spengler, R.N., Smith, C.W.,
and Entman, M.L. (1998). Resident cardiac mast cells degran-
ulate and release preformed TNF-α, initiating the cytokine
cascade in experimental canine myocardial ischemia/reperfu-
sion. Circulation 98, 699 – 710.
Gilles, S., Zahler, S., and Becker, B.F. (2001). Oxidative stress is
essential for postischemic TNFα release of isolated rat hearts.
Pflüger’s Arch. – Eur. J. Physiol. 441 (Suppl.), R235.
Haro, H., Crawford, H.C., Fingleton, B., Shinomiya, K., Spengler,
D.M., and Matrisan, L.M. (2000). Matrix metalloproteinase-7-
dependent release of tumor necrosis factor-α in a model of
herniated disc resorption. J. Clin. Invest. 105, 143 – 150.
Kupatt, C., Habazettl, H., Goedecke, A., Wolf, D.A., Zahler, S.,
Boekstegers, P., Kelly, R.A., and Becker, B.F. (1999). Tumor
necrosis factor-α contributes to ischemia and reperfusion-in-
duced endothelial activation in isolated hearts. Circ. Res. 84,
392 – 400.
Lunn, D.A., Fan, X., Dalie, B., Miller, K., Zavodny, P.J., Narula,
S.K., and Lundell, D. (1997). Purification of ADAM 10 from
bovine spleen as a TNFα convertase. FEBS Lett. 400, 333 –
335.
Massoudy, P., Zahler, S., Freyholdt, T., Henze, R., Barankay, A.,
Becker, B.F., Braun, S.L., and Meisner, H. (2000). Sodium ni-
troprusside in patients with compromised left ventricular func-
tion undergoing coronary bypass: reduction of cardiac proin-
flammatory substances. J. Thorac. Cardiovasc. Surg. 119,
566 – 574.
Milla, M.E., Leesnitzer, M.A., Moss, M.L., Clay, W.C., Carter,
H.L., Miller, A.B., Su, J.L., Lambert, M.H., Willard, D.H., Shee-
ley, D.M. et al. (1999). Specific sequence elements are
required for the expression of functional tumor necrosis fac-
tor-α-converting enzyme (TACE). J. Biol. Chem. 274, 30563 –
30570.
Raschke, P., Becker, B.F., Leipert, B., Schwartz, L.M., Zahler, S.,
and Gerlach, E. (1993). Postischemic dysfunction of the heart
induced by small numbers of neutrophils via formation of
hypochlorous acid. Basic Res. Cardiol. 88, 321 – 339.
Schlöndorff, J., Becherer, D., and Blobel, C.P. (2000). Intracellu-
lar maturation and localization of the tumor necrosis factor α
convertase (TACE). Biochem. J. 347, 131 – 138.
Skovronsky, D.M., Fath, S., Lee, V.M.-Y., and Milla, M.E. (2001).
Neuronal localization of the TNFα converting enzyme (TACE)
in brain tissue and its correlation to amyloid plaques. J. Neu-
robiol. 49, 40 – 46.
Zahler, S., Massoudy, P., Hartl, H., Hähnel, C., Meisner, H., Beck-
er, B.F. (1999). Acute cardiac inflammatory responses to
postischemic reperfusion during cardiopulmonary bypass.
Cardiovasc. Res. 41, 722 – 730.
Zhang, Z., Oliver, P., Lancaster, J.R., Schwarzenberger, P.O.,
Joshi, M.S., Cork, J., and Kolls, J.K. (2001). Reactive oxygen
species mediate tumor necrosis factor α-converting, enzyme-
dependent ectodomain shedding induced by phorbol myris-
tate acetate. FASEB J. 15, 303 – 305.
Received January 18, 2002; accepted August 2, 2002
1826 B.F. Becker et al.
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 24.01.13 13:49
